Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
BeiGene Ltd ( (HK:6160) ) just unveiled an announcement.
BeOne Medicines Ltd. has established a Compensation Committee to oversee the company’s executive compensation plans, policies, and programs. The committee’s primary goal is to attract and retain key management personnel, align management interests with shareholders, and ensure effective talent management and succession planning. The committee is responsible for reviewing and recommending director and executive compensation and producing reports for shareholder meetings, thereby impacting the company’s governance and operational efficiency.
The most recent analyst rating on (HK:6160) stock is a Buy with a HK$148.40 price target. To see the full list of analyst forecasts on BeiGene Ltd stock, see the HK:6160 Stock Forecast page.
More about BeiGene Ltd
Average Trading Volume: 6,619,453
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$235.8B
Find detailed analytics on 6160 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue